Stocks › SRNE

SRNE

SRNE·USD
$0.00
+0.00 (+0.00%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
SRNE
SRNE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
SRNES&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of SRNE by members of U.S. Congress · 2 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Christopher L. JacobsChristopher L. JacobsHouse · R · NY SRNESRNE · Stock Sale
$1,001 - $15,000
Feb 17, 2021 Jan 4, 2021 Filing ↗
Christopher L. JacobsChristopher L. JacobsHouse · R · NY SRNESRNE · Stock Purchase
$1,001 - $15,000
Feb 10, 2021 Dec 28, 2020 Filing ↗

Whale Activity

Position changes in SRNE reported for 2022-12-31 by 6 tracked institutional filers
Increased: 4Held: 1Decreased: 1
  • Increased4
  • New0
  • Held1
  • Decreased1
  • Closed0
  • No prior filing0
FilerSharesValueChange
BlackRock39.4M$34.9Mincreased
Vanguard Group29.5M$26.2Mincreased
D. E. Shaw & Co., Inc.5.1M$4.5Mincreased
Two Sigma Investments, LP302.0K$268Kheld
Citadel Advisors LLC200.1K$177Kdecreased
Millennium Management LLC742.0K$657increased

KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.

Insider Trading

Net shares bought (+) or sold (−) on the open market by SRNE insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

169 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Ji HenrySee Remarks · Director Exercise +300 $5.50 $2K Dec 21, 2022 Form 4 ↗
Ji HenrySee Remarks · Director Grant / award +1.5M $0.00 $0 Dec 15, 2022 Form 4 ↗
Ji HenrySee Remarks · Director Exercise +200 $5.50 $1K Dec 2, 2022 Form 4 ↗
Ji HenrySee Remarks · Director Purchase +88.9K $2.02 $180K Sep 7, 2022 Form 4 ↗
Ji HenrySee Remarks · Director Purchase +55.6K $1.96 $109K Sep 6, 2022 Form 4 ↗
Ji HenrySee Remarks · Director Grant / award +2.5M $0.00 $0 Sep 2, 2022 Form 4 ↗
Ji HenrySee Remarks · Director Purchase +33.3K $2.11 $70K Aug 26, 2022 Form 4 ↗
Ji HenrySee Remarks · Director Purchase +22.2K $2.06 $46K Aug 25, 2022 Form 4 ↗
Ji HenrySee Remarks · Director Purchase +10.0K $1.40 $14K Jun 14, 2022 Form 4 ↗
Janda KimDirector Sale −3,000 $5.88 $18K Dec 27, 2021 Form 4 ↗
Janda KimDirector Option exercise +3,000 $4.00 $12K Dec 27, 2021 Form 4 ↗
Ji HenrySee Remarks · Director Option exercise +10.0K $4.00 $40K Sep 29, 2021 Form 4 ↗
Janda KimDirector Sale −42.4K $8.02 $340K Sep 27, 2021 Form 4 ↗
Janda KimDirector Option exercise +7,357 $3.57 $26K Sep 27, 2021 Form 4 ↗
Janda KimDirector Option exercise +35.0K $1.80 $63K Sep 27, 2021 Form 4 ↗
Janda KimDirector Sale −8,000 $8.04 $64K Sep 13, 2021 Form 4 ↗
Janda KimDirector Option exercise +8,000 $3.50 $28K Sep 13, 2021 Form 4 ↗
Smith Robin LDirector Option exercise +100.0K $4.89 $489K Sep 3, 2021 Form 4 ↗
Smith Robin LDirector Option exercise +75.0K $3.95 $296K Sep 3, 2021 Form 4 ↗
Janda KimDirector Sale −1,900 $6.97 $13K Apr 12, 2021 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding SRNE · SEC Form N-PORT
FundSharesValue% of fundAs of
Guggenheim Active Allocation Fund3,481$20.00%May 29, 2026

Mutual funds and ETFs whose N-PORT filings list SRNE's shares (CUSIP 83587F202), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming SRNE as client

No lobbying filings found naming SRNE as the client.

Government Contracts

Federal awards to SRNE · USAspending

No federal contract awards found for SRNE.

U.S. Patents

Recent USPTO applications naming SRNE

No USPTO patent applications found for SRNE.

Annual Financials

From SRNE's 10-K filings · XBRL

No annual XBRL figures on record for SRNE. KeyVex's fundamentals cover about 130 large companies so far.

Stock Splits

Every split and reverse split in the price history
  • 1-for-25Reverse splitAug 1, 2013
  • 1-for-10Reverse splitOct 7, 2008

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About SRNE

From SEC EDGAR company records

No company profile on record.